Efficacy and Safety of Bexagliflozin, a Selective Sodium-Glucose Cotransporter-2 Inhibitor, in Type 2 Diabetes: A Systematic Review and Meta-Analysis
OBJECTIVE: To summarize the therapeutic effect and safety of bexagliflozin in patients with type 2 diabetes (T2D). MATERIALS AND METHODS: Randomized controlled trials (RCTs) involving patients with T2D receiving bexagliflozin in the intervention arm and either a placebo or any active comparator in t...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Via Medica
2025-01-01
|
| Series: | Clinical Diabetology |
| Subjects: | |
| Online Access: | https://journals.viamedica.pl/clinical_diabetology/article/view/104462 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|